Track: CIBMTR Working Committee
Wednesday, February 11, 2015: 12:15 PM-2:15 PM
Coronado Ballroom AB (Manchester Grand Hyatt)
Chairs:
Steven Z. Pavletic, MD
,
Mitchell S. Cairo, MD
,
Ian Lewis, MBBS, PhD
,
David McKenna, MD
and
Stefanie Sarantopoulos, MD, PhD
Disclosures:
S. Z. Pavletic,
Nothing To Disclose
M. S. Cairo,
New England Fertility, Advisor:
Advisory Board
I. Lewis,
Nothing To Disclose
D. McKenna,
Nothing To Disclose
S. Sarantopoulos,
pharmacyclics honorarium, ad hoc advisory board for chronic gvhd trial using ibrutinib:
Advisory Board
Rigel, nothing financial, we are testing fostamatinib in preclinical studies, rigel may provide drug if we go to clinical trial: fostamatinib supply for lab and potential clinical trial
Rigel, nothing financial, we are testing fostamatinib in preclinical studies, rigel may provide drug if we go to clinical trial: fostamatinib supply for lab and potential clinical trial
Open to All Attendees
See more of: CIBMTR Working Committee